How Will It Be Used?
The recent FDA approval of the Paradise and Symplicity Spyral systems provides a new therapeutic approach to treat resistant hypertension by reducing the activity in the sympathetic nervous system through renal denervation. Both developed after over a decade in development, these devices have been shown to lower blood pressure significantly in patients with hypertension who…